Lanza, F L <br/><br/>
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.  [electronic resource] 

 -  Helicobacter  Sep 1998 
 - 212-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1083-4389 
<br/><br/><label>Standard No.: </label>10.1046/j.1523-5378.1998.08050.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Bismuth--administration & dosage<br/>Clarithromycin--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Duodenal Ulcer--drug therapy<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori<br/>Humans<br/>Male<br/>Middle Aged<br/>Ranitidine--administration & dosage<br/>Recurrence<br/>Treatment Outcome